Healthcare software provider Health Catalyst (NASDAQ:HCAT) beat analysts' expectations in Q4 FY2023, with revenue up 8.6% year on year to $75.08 million. On the other hand, next quarter's revenue guidance of $74.5 million was less impressive, coming in 5.4% below analysts' estimates. It made a non-GAAP profit of $0.02 per share, improving from its loss of $0.05 per share in the same quarter last year.
Related Keywords
Dan Burton , Steve Barlow , Tom Burton , Microsoft , Picking Winners In High Technology , Health Catalyst , Cash Flow , Gorilla Game , Special Free Report , Revenue Guidance , Analyst Estimates , Health , Quarter ,
comparemela.com © 2020. All Rights Reserved.